Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study

Background: Positive associations between inflammatory biomarkers and the risk of heart failure (HF) have been reported in conventional observational studies. However, the causal effects of inflammatory biomarkers on HF have not been fully elucidated. We conducted a Mendelian randomization (MR) stud...

Full description

Bibliographic Details
Main Authors: Xintao Li, Shi Peng, Bo Guan, Songwen Chen, Genqing Zhou, Yong Wei, Chao Gong, Juan Xu, Xiaofeng Lu, Xiaoyu Zhang, Shaowen Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.734400/full
_version_ 1818823059560202240
author Xintao Li
Shi Peng
Bo Guan
Songwen Chen
Genqing Zhou
Yong Wei
Chao Gong
Juan Xu
Xiaofeng Lu
Xiaoyu Zhang
Xiaoyu Zhang
Shaowen Liu
author_facet Xintao Li
Shi Peng
Bo Guan
Songwen Chen
Genqing Zhou
Yong Wei
Chao Gong
Juan Xu
Xiaofeng Lu
Xiaoyu Zhang
Xiaoyu Zhang
Shaowen Liu
author_sort Xintao Li
collection DOAJ
description Background: Positive associations between inflammatory biomarkers and the risk of heart failure (HF) have been reported in conventional observational studies. However, the causal effects of inflammatory biomarkers on HF have not been fully elucidated. We conducted a Mendelian randomization (MR) study to examine the possible etiological roles of inflammatory biomarkers in HF.Methods: Summary statistical data for the associations between single nucleotide polymorphisms (SNPs) and C-reactive protein (CRP), fibrinogen, and components of the interleukin-1 (IL-1)-interleukin-6 (IL-6) inflammatory signaling pathway, namely, interleukin-1β (IL-1β), IL-1 receptor antagonist (IL-1ra), IL-6, and soluble IL-6 receptor (sIL-6r), were obtained from genome-wide association studies (GWASs) for individuals of European descent. The GWAS dataset of 977,323 participants of European ancestry, which included 47,309 HF cases and 930,014 controls, was collected to identify genetic variants underlying HF. A two-sample Mendelian randomization framework was implemented to examine the causality of the association between these inflammatory biomarkers and HF.Results: Our MR analyses found that genetically determined CRP and fibrinogen were not causally associated with HF risk (odds ratio [OR] = 0.93, 95% confidence interval [CI] = 0.84–1.02, p = 0.15; OR = 0.94, 95% CI = 0.55–1.58, p = 0.80, respectively). These findings remained consistent using different Mendelian randomization methods and in sensitivity analyses. For the IL-1-IL-6 pathway, causal estimates for IL-6 (OR = 0.86, 95% CI 0.81–0.91, p < 0.001), but not for IL-1β, IL-1ra, or sIL-6r, were significant. However, the association between genetically determined IL-6 and HF risk became non-significant after excluding SNPs with potential pleiotropy (OR = 0.89, 95% CI = 0.77–1.03, p = 0.12).Conclusion: Our study did not identify convincing evidence to support that CRP and fibrinogen, together with their upstream IL-1-IL-6 signaling pathway, were causally associated with HF risk.
first_indexed 2024-12-18T23:33:57Z
format Article
id doaj.art-93a5a3a74b6947c583aaa09bad956236
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-18T23:33:57Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-93a5a3a74b6947c583aaa09bad9562362022-12-21T20:47:37ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-11-01810.3389/fcvm.2021.734400734400Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization StudyXintao Li0Shi Peng1Bo Guan2Songwen Chen3Genqing Zhou4Yong Wei5Chao Gong6Juan Xu7Xiaofeng Lu8Xiaoyu Zhang9Xiaoyu Zhang10Shaowen Liu11Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaGeriatric Cardiology Department of the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, ChinaDepartment of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, ChinaDepartment of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground: Positive associations between inflammatory biomarkers and the risk of heart failure (HF) have been reported in conventional observational studies. However, the causal effects of inflammatory biomarkers on HF have not been fully elucidated. We conducted a Mendelian randomization (MR) study to examine the possible etiological roles of inflammatory biomarkers in HF.Methods: Summary statistical data for the associations between single nucleotide polymorphisms (SNPs) and C-reactive protein (CRP), fibrinogen, and components of the interleukin-1 (IL-1)-interleukin-6 (IL-6) inflammatory signaling pathway, namely, interleukin-1β (IL-1β), IL-1 receptor antagonist (IL-1ra), IL-6, and soluble IL-6 receptor (sIL-6r), were obtained from genome-wide association studies (GWASs) for individuals of European descent. The GWAS dataset of 977,323 participants of European ancestry, which included 47,309 HF cases and 930,014 controls, was collected to identify genetic variants underlying HF. A two-sample Mendelian randomization framework was implemented to examine the causality of the association between these inflammatory biomarkers and HF.Results: Our MR analyses found that genetically determined CRP and fibrinogen were not causally associated with HF risk (odds ratio [OR] = 0.93, 95% confidence interval [CI] = 0.84–1.02, p = 0.15; OR = 0.94, 95% CI = 0.55–1.58, p = 0.80, respectively). These findings remained consistent using different Mendelian randomization methods and in sensitivity analyses. For the IL-1-IL-6 pathway, causal estimates for IL-6 (OR = 0.86, 95% CI 0.81–0.91, p < 0.001), but not for IL-1β, IL-1ra, or sIL-6r, were significant. However, the association between genetically determined IL-6 and HF risk became non-significant after excluding SNPs with potential pleiotropy (OR = 0.89, 95% CI = 0.77–1.03, p = 0.12).Conclusion: Our study did not identify convincing evidence to support that CRP and fibrinogen, together with their upstream IL-1-IL-6 signaling pathway, were causally associated with HF risk.https://www.frontiersin.org/articles/10.3389/fcvm.2021.734400/fullheart failureMendelian randomizationC-reactive proteinfibrinogeninterleukin
spellingShingle Xintao Li
Shi Peng
Bo Guan
Songwen Chen
Genqing Zhou
Yong Wei
Chao Gong
Juan Xu
Xiaofeng Lu
Xiaoyu Zhang
Xiaoyu Zhang
Shaowen Liu
Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
Frontiers in Cardiovascular Medicine
heart failure
Mendelian randomization
C-reactive protein
fibrinogen
interleukin
title Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
title_full Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
title_fullStr Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
title_full_unstemmed Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
title_short Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study
title_sort genetically determined inflammatory biomarkers and the risk of heart failure a mendelian randomization study
topic heart failure
Mendelian randomization
C-reactive protein
fibrinogen
interleukin
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.734400/full
work_keys_str_mv AT xintaoli geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT shipeng geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT boguan geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT songwenchen geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT genqingzhou geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT yongwei geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT chaogong geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT juanxu geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT xiaofenglu geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT xiaoyuzhang geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT xiaoyuzhang geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy
AT shaowenliu geneticallydeterminedinflammatorybiomarkersandtheriskofheartfailureamendelianrandomizationstudy